Clinical Trials Sponsored by ISTAR Medical

Total 55408 results

iSTAR Medical

Completed

MINIject in Patients With Open Angle Glaucoma Using Single Operator Delivery Tool

Glaucoma, Open-Angle | Glaucoma Eye

Panama, Colombia, India
iSTAR Medical

Active, not recruiting

STAR-LIFE Registry: STARflo Glaucoma Implant Clinical Experience Program

Open Angle Glaucoma

Spain, Germany, Belgium, France, Hungary
iSTAR Medical

Completed

STARflo European Safety and Efficacy Study

Open Angle Glaucoma

Belgium, Germany, Bulgaria, France, Switzerland
iSTAR Medical

Recruiting

Evaluate the Safety and Effectiveness of iSTAR Medical's MINIject™ Implant for Lowering Intraocular Pressure (IOP) in Subjects With Primary Open-angle Glaucoma. (STAR-V)

Glaucoma

United States
iSTAR Medical

Recruiting

MINIject Global Long-Term Follow-up Study (STAR-GLOBAL)

Ocular Hypertension | Open Angle Glaucoma

Germany, Spain, Colombia, France, India, Panama
iSTAR Medical

Enrolling by invitation

MINIject Implantation Combined With Cataract Surgery in Patients With POAG and Cataract (STAR-VI)

Cataract | Primary Open-angle Glaucoma

Spain, Panama, United Kingdom
iSTAR Medical

Completed

MINIject Glaucoma Implant in European Patients (STAR-II)

Glaucoma, Open-Angle | Intraocular Pressure | Glaucoma Eye

France, Germany, Spain
iSTAR Medical

Completed

MINIject in Patients With Open Angle Glaucoma Uncontrolled by Topical Hypotensive Medications (STAR-I)

Open Angle Glaucoma

India, Panama
iSTAR Medical

Recruiting

STAR-LIFE: a Post-market Registry on MINIject (STAR-LIFE)

Open Angle Glaucoma

Switzerland
iSTAR Medical

Completed

MINIject 636 in Patients With Open Angle Glaucoma Uncontrolled by Topical Hypotensive Medications

Open Angle Glaucoma

Colombia, India, Panama
iSTAR Medical
International Drug Development Institute

Active, not recruiting

MINIject (MINI SO627) in Patients With Open Angle Glaucoma Using Single Operator Delivery Tool

Glaucoma, Open-Angle Glaucoma Eye

India, Panama
Istari Oncology, Inc.

Active, not recruiting

LUMINOS-102: Lerapolturev With or Without Immune Checkpoint Blockade in Advanced PD-1 Refractory Melanoma

Melanoma

United States
Istari Oncology, Inc.

Active, not recruiting

LUMINOS-101: Lerapolturev (PVSRIPO) and Pembrolizumab in Patients With Recurrent Glioblastoma

Glioblastoma | Brain Tumor | Recurrent Glioblastoma | Supratentorial Glioblastoma

United States
Istari Oncology, Inc.

No longer available

EAP for the Treatment of Glioblastoma With PVSRIPO

Glioblastoma

United States
The Wistar Institute

Completed

Immune and Viral Outcomes of HIV-1 Therapy Interruption

HIV Infections

United States
ISAR Klinikum

Active, not recruiting

Influence of RIC on the Orthostatic Competence of the Microcirculation

Orthostatic Intolerance | Remote Ischemic Preconditioning | Hemodynamics | Microcirculation

Germany
Istari Oncology, Inc.

Active, not recruiting

LUMINOS-103: A Basket Trial Evaluating the Safety and Efficacy of Lerapolturev (PVSRIPO) and Lerapolturev in Combination With Anti-PD-1/L1 Checkpoint Inhibitors in Patients With Advanced Solid Tumors

Solid Tumor | Bladder Cancer | Non-muscle-invasive Bladder Cancer

United States
Ostar Meditech Corp

Completed

Assessment of the Clinical Efficacy of the Heart Spectrum Blood Pressure Monitor for Diagnosis of Atrial Fibrillation

Atrial Fibrillation
The Wistar Institute

Completed

Anti-HIV Treatment Interruptions in HIV Infected Adults in South Africa

HIV Infections

South Africa
Star Scientific, Inc

Completed

A Pilot Study to Evaluate the Efficacy and Safety of Ariva® Silver Wintergreen in Healthy Smokers

Smoking | Tobacco Use Disorder

United States
Star Scientific, Inc

Completed

A Pilot Study to Evaluate the Efficacy of Ariva® Silver Wintergreen, a Smoking Aversive Lozenge

Smoking | Tobacco Use Disorder

United States
Star Scientific, Inc

Completed

Pilot Study to Evaluate the Safety and Efficacy of Ariva® Silver Wintergreen in Reducing Cigarette Craving in Smokers

Smoking | Tobacco Use Disorder

United States
Baylor Research Institute
Southern Star Medical Research Institute

Recruiting

Expanded Population Health Model Evaluation

Quality of Life | Chronic Disease

United States
Klinik Bogenhausen
ISAR Klinikum

Completed

Efficacy of Postoperative Epidural Anesthesia Following Abdominoplasty (EDA)

Anesthesia | Abdominoplasty

Germany
Star Spine and Sport

Completed

Effectiveness of Ultrasound Guided Platelet Rich Plasma Injections in the Sacroiliac Joint

Chronic Low Back Pain | Treatment | Platelet | Ultrasound Therapy; Complications | Sacroiliitis | Injection Site | Platelet Rich Plasma | Sacroiliac; Backache

United States
Istari Oncology, Inc.
Duke University

Active, not recruiting

PVSRIPO in Recurrent Malignant Glioma

Malignant Glioma

United States
F-star Therapeutics, Inc.

Completed

A Study Evaluating the Safety, Pharmacokinetics, and Antiviral Efficacy of SB 9200 in Subjects Infected With Chronic HBV (ACHIEVE)

Hepatitis B | Hepatitis, Viral

Canada, Hong Kong, Korea, Republic of, Taiwan
F-star Therapeutics, Inc.
CSI Medical Research Pte Ltd

Terminated

Evaluating the Effects of Inarigivir on Immune Response and Viral Markers in Chronic Hepatitis B Patients

Hepatitis B | Hepatitis B, Chronic | HBV

Singapore
Istari Oncology, Inc.
Duke University

Completed

PVSRIPO for Patients With Unresectable Melanoma

Melanoma

United States
Twin Star Medical, Inc.
United States Department of Defense

Unknown

Double Blinded, Randomized Clinical Trial of the Twin Star ECSPRESS Monitoring System for the Reduction of the Incidence of Fasciotomy (ECSPRESS)

Compartment Syndrome

United States
Twin Star Medical, Inc.
United States Department of Defense

Unknown

Study of New Catheter & Pressure Monitor System to Help Prevent Compartment Syndrome From Developing in the Injured Leg (TS2)

Compartment Syndrome

United States
Darell Bigner
Istari Oncology, Inc.

Not yet recruiting

Lerapolturev (PVSRIPO) in GBM

Recurrent Supratentorial Glioblastoma

United States
Syneos Health
F-star Therapeutics, Inc.

Completed

A Multiple Ascending Dose Phase I Study of SB 9200 in Treatment Naïve Adults With Chronic Hepatitis C Infection

Hepatitis C Infection

Australia, New Zealand
Gilead Sciences
F-star Therapeutics, Inc.

Terminated

Study to Evaluate the Safety and Antiviral Activity of Inarigivir Soproxil (Formerly: GS-9992) Plus Tenofovir Alafenamide (TAF) for 12 Weeks in Adults With Chronic Hepatitis B (CHB)

Chronic Hepatitis B

Korea, Republic of, Hong Kong
FHI 360
Gold Star Kenya (GSKenya)

Completed

Evaluation of a Peer Education Program to Promote Family Planning Among Female Sex Workers in Kenya

Contraception

Kenya
BEMFAM-Bem Estar Familiar
Merck Sharp & Dohme LLC

Completed

The Psychosocial and Economic Burden of Genital Warts (GWburden)

Female Genital Warts
F-star Therapeutics, Inc.
PRA Health Sciences

Completed

A Fixed-Sequence, Drug-Drug Interaction Study Between Multiple Oral Doses of Inarigivir Soproxil and a Single Oral Dose of Midazolam in Healthy Subjects

Drug Interaction Potentiation

Netherlands
F-star Therapeutics, Inc.
PRA Health Sciences

Terminated

Evaluating the Safety and Efficacy of Inarigivir in Non-cirrhotic Treatment Naive Subjects Infected With Hepatitis B Virus

Hepatitis B | Hepatitis B, Chronic | HBV

Hong Kong
E-Star BioTech, LLC
Mayo Clinic; PPD

Not yet recruiting

To Evaluate the Safety and Efficacy of MANP in Subjects With Difficult to Control/ Resistant Hypertension

Difficult to Control Hypertension
Biosion, Inc.
Southern Star Research Pty Ltd.

Completed

Safety and Tolerability of BSI-045B in Healthy Adult Subjects and Patients With Atopic Dermatitis

Atopic Dermatitis

Australia
Cytonics Corporation
Southern Star Research Pty Ltd.

Not yet recruiting

Evaluation of CYT-108, a Recombinant Protease Inhibitor, for Treatment of Mild to Moderate Primary Osteoarthritis of the Knee

Osteoarthritis | Osteoarthritis, Knee

Australia
E-Star BioTech, LLC
Mayo Clinic; Integrium

Completed

Safety And Tolerability Of Subcutaneous MANP In Difficult To Control/Resistant Hypertensive Subjects (DTC/RHS)

Resistant Hypertension | Difficult to Control Hypertension

United States
F-star Therapeutics, Inc.
PRA Health Sciences

Terminated

Evaluating the Safety and Efficacy of Inarigivir in Non-cirrhotic, Hepatitis B e Antigen-negative Subjects Infected With HBV Virus and Receiving or Stopping Treatment With a NUC Inhibitor

Hepatitis B | Hepatitis B, Chronic | HBV

Canada, United Kingdom
Taipei Veterans General Hospital, Taiwan
iStat Biomedical CO., Ltd.

Completed

Validation of DNA Methylation Biomarkers for Oral Cancer Detection

Recurrence | Oral Cancer

Taiwan
Darell Bigner
Genentech, Inc.; Istari Oncology, Inc.

Withdrawn

Combination of PVSRIPO and Atezolizumab for Adults With Recurrent Malignant Glioma

Malignant Glioma
University of Melbourne
Southern Star Research Pty Ltd.

Completed

Safety and Immune Response of Adjuvanted SARS-CoV-2 (COVID-19) Beta Variant RBD Recombinant Protein (DoCo-Pro-RBD-1 + MF59®) and mRNA (MIPSCo-mRNA-RBD-1) Vaccines in Healthy Adults

SARS-CoV-2

Australia
Virginia Polytechnic Institute and State University
Vistar Eye Center

Recruiting

The Role of Loteprednol in Reducing Post-Intravitreal Injection Related Pain

Age-Related Macular Degeneration

United States
Luis Montaner
Merck Sharp & Dohme LLC

Not yet recruiting

A Pilot Study to Evaluate Alternative Viral Load Tests During Start of Antiretroviral Therapy

HIV-1-infection
Istari Oncology, Inc.
United States Department of Defense; Duke University

Completed

Examining Bioactivity of PVSRIPO in Invasive Breast Cancer

Invasive Breast Cancer

United States
The Wistar Institute
University of Pennsylvania; Merck Sharp & Dohme LLC

Completed

Pilot Peg-Interferon-a2b in Decreasing Viral DNA in HIV

HIV-1 Infection

United States

Clinical Trials Sponsored by ISTAR Medical

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Croatia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations